Aerospace Update | August 2026
Tripling Down on Space: U.S. Space Force Expands Launch Contracts to $17B, Raising the Stakes for IP Michael E. Salamy The Space Force’s decision to triple the size of its...
Life Science Update | August 2026
No “Duty to Innovate” – California’s Highest Court Finds Gilead Sciences Not Negligent for Delaying Release of Allegedly Safer HIV Drug Ari Feinstein & Rhett D. Ramsey California court holds...
Litigation Update | August 2026
Typos Cause Alkanes of Trouble Ben K. Shiroma & Ryan M. Newell A patentee could not argue that its provisional application provided written description support for its issued claims by arguing...
Managing IP Quotes Jarom Kesler On How Patent Examiner Analytics Can Shape USPTO Prosecution Strategy
Knobbe Martens partner Jarom Kesler discussed how U.S. Patent and Trademark Office (USPTO) patent examiner statistics can inform patent prosecution strategy in a recent Managing Intellectual Property article. The article...
Knobbe Martens Partners Named Among Global IP Leaders in IAM Strategy 300 Guide
IRVINE, Calif., August 14, 2026 – Knobbe Martens is proud to share that eight of the firm’s partners were recognized in the 2026 edition of IAM Strategy 300: The World’s...
Understanding AI and Patent Eligibility
In this episode of Knobbe IP+, Knobbe Martens partners Jarom Kesler and Bryan McWhorter discuss the latest developments in AI and patent eligibility. Sharing insights for both fellow IP practitioners and...
Jarom Kesler Comments on Ex Parte Review Trends at the USPTO in Bloomberg Law Interview
In an interview with Bloomberg Law, Knobbe Martens partner Jarom Kesler shared his perspective on the latest trends in institution rates of ex parte reviews (EPRs) at the U.S. Patent...
Jarom Kesler Explores Patent-Term Adjustment in the Post-Forest Era in IPWatchdog Article
In a recent article published in IPWatchdog, Knobbe Martens partner Jarom Kesler explores the impact of In re Forest, a 2025 Federal Circuit decision that addressed the question, “What value...
PTAB Update | May 2026
USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board Ted M. Cannon In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc.,...
Knobbe Martens, Dozens of Partners Receive Top Rankings in IP Law in Legal 500 USA Guide
IRVINE, Calif., June 11, 2026 – Knobbe Martens, a leading intellectual property law firm, is proud to share that the firm and three dozen lawyers received national and regional recognition...
Jarom Kesler Comments on USPTO Ex Parte Reexamination Denial Trends in Law360
In the Law360 article “USPTO Clamping Down Reexam Bids After IPR Denials,” Knobbe Martens partner Jarom Kesler shared how a recent ruling from the U.S. Patent and Trademark Office (USPTO)...
Life Science Update | May 2026
AI Risks With the Patent Office: What Life Science Companies Should Be Asking Now Robert J. Hilton, Ph.D. & Justin Culbertson, Ph.D. AI tools are reshaping patent preparation and prosecution,...
Joshua Martineau and Jarom Kesler Explore New USPTO Procedure for Ex Parte Reexamination in Law360
In a recent article published in Law360, Knobbe Martens lawyers Joshua Martineau and Jarom Kesler explore the U.S. Patent and Trademark Office (USPTO)’s latest guidance regarding ex parte reexamination (EPR)...
PTAB Update | April 2026
USPTO Introduces Pre-Order Papers for Patent Owners in Ex Parte Reexaminations Jarom D. Kesler & Joshua M. Martineau With the decline of inter partes review (IPR) proceedings and the significant...
SMEDs Are Working: What the USPTO’s Updated § 101 Patent Eligibility Guidance Means for Innovators
Key Takeaway: The U.S. Patent and Trademark Office’s April 30, 2026 memorandum encourages patent applicants to submit separate declarations supporting “subject matter eligibility” (SMEDs) in response to § 101 rejections....
USPTO Introduces Pre-Order Papers for Patent Owners in Ex Parte Reexaminations
Key Takeaway: With the decline of inter partes review (IPR) proceedings and the significant increase in ex parte reexamination (EPR) proceedings, the U.S. Patent and Trademark Office (USPTO) is allowing...
In Law360 Interview, Jarom Kesler Offers Insights on How Law Firms Are Adopting AI Tools
In the Law360 article “IP Firms Are Navigating AI Era With Range Of Guardrails,” Knobbe Martens partner Jarom Kesler discussed the firm’s approach to the adoption and integration of generative...
In Managing IP Interview, Jarom Kesler Discusses How the Government Shutdown Affected IP Practices
In a recent interview with Managing Intellectual Property, partner Jarom Kesler offered insight into the impact of the recently concluded U.S. government shutdown on intellectual property law proceedings, including the...
Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case
IRVINE, Calif., November 17, 2025 – A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo’s patented heart...
Litigation Update | October 2025
Standing or Guesswork? A Speculative Risk of Patent Cancellation is Insufficient for Standing Jacob R. Rosenbaum & Jordan A. DeOrio US INVENTOR, INC. v. UNITED STATES PATENT AND TRADEMARK OFFICE Before Lourie, Reyna,...
In Federal News Network Interview, Jarom Kesler Discusses Impact of Government Shutdown on IP and Patent Litigation
In a recent interview with Federal News Network, Knobbe Martens partner Jarom Kesler provided insights into the impact of the government shutdown on intellectual property law, including how the United...
